TH167910A - Pharmaceutical mixtures for the prevention or treatment of hyperlipidemia. - Google Patents
Pharmaceutical mixtures for the prevention or treatment of hyperlipidemia.Info
- Publication number
- TH167910A TH167910A TH1401002985A TH1401002985A TH167910A TH 167910 A TH167910 A TH 167910A TH 1401002985 A TH1401002985 A TH 1401002985A TH 1401002985 A TH1401002985 A TH 1401002985A TH 167910 A TH167910 A TH 167910A
- Authority
- TH
- Thailand
- Prior art keywords
- prevention
- treatment
- hyperlipidemia
- substance
- onyx
- Prior art date
Links
- 206010062060 Hyperlipidaemia Diseases 0.000 title claims abstract 4
- 239000000203 mixture Substances 0.000 title claims 3
- 230000002265 prevention Effects 0.000 title claims 3
- 239000000126 substance Substances 0.000 claims abstract 5
- 241001644482 Onyx Species 0.000 claims abstract 4
- 102000008873 Angiotensin II receptor Human genes 0.000 claims abstract 3
- 108050000824 Angiotensin II receptor Proteins 0.000 claims abstract 3
- 239000003087 receptor blocking agent Substances 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 239000011780 sodium chloride Substances 0.000 claims abstract 3
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract 2
- 239000005480 Olmesartan Substances 0.000 claims 2
- VTRAEEWXHOVJFV-UHFFFAOYSA-N olmesartan Chemical compound CCCC1=NC(C(C)(C)O)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 VTRAEEWXHOVJFV-UHFFFAOYSA-N 0.000 claims 2
- 229960005117 olmesartan Drugs 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 150000004102 olmesartan derivatives Chemical class 0.000 claims 1
- 230000003449 preventive Effects 0.000 abstract 1
Abstract
DC60 การประดิษฐ์ที่เสนอนี้จัดให้สารผสมทางเภสัชกรรมสารหนึ่งสำหรับการป้องกันหรือการ รักษาภาวะไขมันในเลือดสูง ซึ่งประกอบรวมด้วย (4S,5R)-5-[3,5-บิส(ไตรฟลูออโรเมทิล)ฟี นิล]-3-({2-[4-ฟลูออโร-2-เมทอกซี-5-(โพรพาน-2-อิล)ฟีนิล]-5-(ไตรฟลูออโรเมทิล)ฟีนิล} เมทิล)-4-เมทิล-1,3-ออกซะโซลิดิน-2-โอน หรือเกลือที่ยอมรับได้ทางเภสัชกรรมของสารนี้ และ ตัวปิดกั้นแอนจิโอเทนซิน II รีเซปเตอร์ตัวหนึ่งในฐานะเป็นอินเกรเดียนท์ที่แอคทีฟ สิทธิบัตรยา DC60 The proposed invention provides a single pharmaceutical admixture for preventive or Treat hyperlipidemia Which includes (4S, 5R) -5- (3,5-bis (trifluoromethyl) phen Onyx] -3 - ((2- [4-fluoro-2-moxy-5- (propan-2-il) phenyl) -5- (trifluoromethyl) phenyl) Onyx) methyl) -4-methyl -1,3-oxasolidin-2-transfer Or a chemically acceptable salt of this substance and an angiotensin II receptor blocker as an active drug patent integral.
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH167910A true TH167910A (en) | 2017-09-21 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2007002268A1 (en) | PROCEDURE FOR THE PREPARATION OF COMPOUNDS DERIVED FROM OPTICALLY ACTIVE CYCLOPROPYLAMINE; INTERMEDIARY COMPOUND DERIVED FROM 2-ARIL OPTICALLY ACTIVE CYCLOPROPANCARBOXAMIDE. | |
| EA200870521A1 (en) | SUBSTITUTED SPIROCYCLIC ANTAGONISTS OF CGRP RECEPTORS | |
| EA201170772A1 (en) | ORGANIC COMPOUNDS | |
| EA201001680A1 (en) | COMPOUNDS OF BENZOLSULPHONAMIDTIAOSOL AND OXAZOL | |
| CL2007003758A1 (en) | COMPOUNDS DERIVED FROM AMINOPIRIMIDINE, INHIBITORS OF PLK1; PHARMACEUTICAL COMPOSITION, USEFUL FOR CANCER TREATMENT. | |
| MA35172B1 (en) | Pesticular mixtures containing isoxazoline derivatives | |
| ATE482939T1 (en) | NEW ANTIMICROBIAL COMPOUNDS, THEIR SYNTHESIS AND THEIR USE FOR THE TREATMENT OF MAMMAL INFECTIONS | |
| HRP20080552A2 (en) | Benzimidazole derivative and use thereof | |
| EA201170828A1 (en) | CONDENSED HETEROCYCLIC DERIVATIVES OF OXADIAZOL, SUITABLE FOR THE TREATMENT OF SCATTERED SCLEROSIS | |
| EA201200868A1 (en) | INHIBITORS DIACYL GLYCEROLACILTRANSFERASE | |
| MD4215B1 (en) | Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide | |
| TH167910A (en) | Pharmaceutical mixtures for the prevention or treatment of hyperlipidemia. | |
| UA92485C2 (en) | Benzimidazole derivative and use thereof as angiotensin ii antagonist | |
| DK2089030T3 (en) | Drug for prophylaxis or treatment of alcohol dependence or drug dependence | |
| MX2014006448A (en) | Pharmaceutical composition for preventing or treating hyperlipidemia. | |
| TH168717A (en) | Pharmaceutical mixtures for the prevention or treatment of high triglycerides in the blood. Or diseases associated with high levels of triglycerides in the blood | |
| CR20110342A (en) | CYCLOPROPYL COMPOUNDS | |
| ATE539066T1 (en) | COMPOUNDS CONTAINING ORGANOSELS AND THEIR USE | |
| TH115350B (en) | Two-way antihypertensive agents | |
| TH114616B (en) | Antihypertensive agents that show dual activity. | |
| TH149010B (en) | Dihydroquinasoline replaced | |
| TH155318A (en) | Co-crystals and salts of CCR3 inhibitors | |
| TH135246B (en) | Aeril Sulfonamied CCR3 Antagonist | |
| TH141815A (en) | Kinase inhibitors, which have an improved CYP safety profile. | |
| ATE482951T1 (en) | BENZIMIDAZOLE DERIVATIVE AND USE THEREOF |